The Profile of Cervical Cancer Patients at Soedarso Hospital

Sari Eka Pratiwi, Heru Fajar Trianto, Nabilah Nurul Fatinah, Muhammad In’am Ilmiawan, Iit Fitrianingrum, Desriani Lestari


Background: The prevalence and mortality rates of cervical cancer differ by region with the highest rates found in Latin America, Southeast Asia, and Africa. In Indonesia, cervical cancer is the second-largest contributor to the latest cases in 2020. In West Kalimantan, over 20,000 women were diagnosed with cervical cancer in 2014. This study aims to describe the characteristics of cervical cancer patients in West Kalimantan.


Methods: A descriptive observational study was conducted on patients from 2017 to 2019 according to the Soedarso Hospital database. All medical records were reviewed and analyzed to obtain the variable data; they were age, ethnics, origin, stage of cervical cancer, histopathology types, and hemoglobin (Hb) level.


Results: Cervical cancer patients for the 2017–2019 period totaled 147 people with 30 deaths. In this study, 97 patients from 2017 to 2019 met the inclusion criteria. Cervical cancer was found from the age of 27 years with a peak at the age of 41–60 years. Most patients came from Pontianak and Kubu Raya cities (45.4% and 14.4%, respectively) with the most ethnic groups being Malays (41.2%). A total of 43.3% of patients had a parity amount of more than five times. Most patients came at stage IIIb (45.4%). The patients present with moderate to severe anemia with the lowest Hb level of around 2.3 g/dL. Based on histopathology, the type of squamous cell carcinoma ranks the highest (70.1%).


Conclusions: Cervical cancer incidence reaches the peak at adults to elderly. The amount of parity seems to contribute to the incidence of cervical cancer in West Kalimantan. Most patients came at an advanced stage and the type of squamous cell carcinoma with moderate to severe anemia


cervical cancer, epidemiology, histopathology, patients’ haracteristics


World Health Organization. Cancer Statistic 2020. Globocan 2020. 2020;419:1–2.

Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer. 2007;7(164):1–13.

Astuti W. Efektifitas Pemeriksaan Inspeksi Visual Asam Asetat ( Iva ) Sebagai Deteksi Dini Pra - Kanker Serviks Di Puskesmas Sungai Kakap Kabupaten Kubu Raya Tahun 2017. J Kebidanan Khatulistiwa. 2020;6(2):78–82.

Jenkins D. Histopathology and cytopathology of cervical cancer. Dis Markers. 2007;23(4):199–212.

Winer I, Alvarado-Cabrero I, Hassan O, et al. The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study. Gynecol Oncol. 2015;137(3):474–8.

González Martín A. Molecular biology of cervical cancer. Clin Transl Oncol. 2007;9(6):347–54.

Lin M, Ye M, Zhou J, Wang ZP, Zhu X. Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies. Comput Struct Biotechnol J. 2019;17(109):241–50.

Putri AR, Khaerunnisa S, Yuliati I. Cervical Cancer Risk Factors Association in Patients at the Gynecologic-Oncology Clinic of Dr. Soetomo Hospital Surabaya. Indones J Cancer. 2019;13(4):104.

Kementerian Kesehatan RI. Laporan Riskesdas 2018. Lap Nas RIskesdas 2018 [Internet]. 2018;53(9):181–222. Available from: No. 57 Tahun 2013 tentang PTRM.pdf

Balaya V, Guani B, Magaud L, et al. Validation of the 2018 figo classification for cervical cancer: Lymphovascular space invasion should be considered in ib1 stage. Cancers (Basel). 2020;12(12):1–14.

Rajendiran S, Gopalan U, Karnaboopathy R. Evaluation of histopathology of cervix in women with unhealthy cervix. Int J Reprod Contraception, Obstet Gynecol. 2017;6(3):842.

American Cancer Society. Cervical Cancer Early Detection, Diagnosis, and Staging Can Cervical Cancer Be Found Early ? American Cancer Society. 2019. 1–32 p.

Castañón A, Landy R, Cuzick J, Sasieni P. Cervical Screening at Age 50-64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study. PLoS Med. 2014;11(1):e1001585.

Seamon LG, Java JJ, Monk BJ, et al. Impact of tumour histology on survival in advanced cervical carcinoma: An NRG Oncology/Gynaecologic Oncology Group Study. Br J Cancer. 2018;118(2):162–70.

Rozario S do, Silva IF da, Koifman RJ, Silva IF da. Characterization of women with cervical cancer assisted at Inca by histological type. Rev Saude Publica. 2019;53(88):1–12.

Hossain N, Perveen R, Mahmud MS, Hassan MK. Prognostic Impact of Histopathology in Patients with Advanced Stage Cervical Carcinoma Treated with Radiotherapy. J Bangladesh Coll Physicians Surg. 2019;37(4):175–80.

Hasugian SA, Lubis K, Doan H V. Profile of Histopathology of Cervical Cancer Tissues in Patients of the Dr Pirngadi Medan Hospital. J Biosains. 2020;6(3):90.

Matsuo K, Mandelbaum RS, Machida H, et al. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol. 2018;29(6):1–12.

Xie L, Chu R, Wang K, et al. Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach. Front Oncol. 2020;10(August):1–11.

Nuranna L, Prastasari R, Sutrisna B. Survival of cervical cancer patients and its prognostic factors at Cipto Mangunkusumo Hospital, Jakarta. Med J Indones. 2014;23(3):163–8.

Glaze S, Duan Q, Sar A, et al. FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix. J Obstet Gynaecol Canada. 2019;41(9):1318–24.

Kashyap N, Krishnan N, Kaur S, Ghai S. Risk Factors of Cervical Cancer : A Case ‑ Control Study. Asia‑Pacific J Oncol Nurs. 2019;6(3):308–14.

Smith JS. Ethnic disparities in cervical cancer illness burden and subsequent care: A prospective view in managed care. Am J Manag Care. 2008;14(SUPPL. 6):193–200.

Marlow LAV, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: A qualitative study. J Fam Plan Reprod Heal Care. 2015;41(4):248–54.

Adams GG. Does ethnicity and culture affect the non-compliancy of cervical cancer screening?”. MOJ Public Heal. 2018;7(4):219–27.

Dalton HJ, Farley JH. Racial disparities in cervical cancer: Worse than we thought. Cancer. 2017;123(6):915–6.

Barkati M, Fortin I, Mileshkin L, et al. Hemoglobin level in cervical cancer: A surrogate for an infiltrative phenotype. Int J Gynecol Cancer. 2013;23(4):724–9.

Bishop AJ, Allen PK, Klopp AH, et al. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: Has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015;91(1):196–205.

Full Text: PDF

DOI: 10.33371/ijoc.v16i1.845

Article Metrics

Abstract view : 173 times
PDF - 155 times


  • There are currently no refbacks.

Copyright (c) 2022 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.